SDZXF:OTCMKTS
Sandoz Group AG
84,03 USD
0,00%
(0,00) 1D
23-сен., 15:20:07 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZXF...
Mkt. cap
30,18 млд
Avg. vol.
122,00
Volume
5,00
52-wk high
94,55 USD
52-wk low
58,48 USD
Shares outstanding
440,00 млн
No. of employees
20 миң
Mkt. cap
30,18 млд
Avg. vol.
122,00
Volume
5,00
52-wk high
94,55 USD
52-wk low
58,48 USD
Shares outstanding
440,00 млн
No. of employees
20 миң
News stories
From web sources and news partners
roundtable.io
·
40 мүнөт мурун
TOKEN2049 Singapore brings Nasdaq's CEO, F1 Champions, and crypto's biggest founders under one roof
Pulse 2.0
·
48 мүнөт мурун
Vylor Completes Corteva Spin-Off And Begins Trading On NYSE
GlobeNewswire
·
1 саат мурун
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Yahoo Finance
·
19 мүнөт мурун
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG
CEORichard Saynor
Employees20 миң
Founded1886
Headquarters-
SectorPharmaceutical industry
Websitesandoz.com